carbidopa has been researched along with Hyperactivity, Motor in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (57.14) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Di Vico, IA; Novelli, A; Ramat, S; Sorbi, S; Terenzi, F | 1 |
| Anastasia, A; Carli, M; Invernizzi, RW; Kostoula, C; Mainolfi, P; Sacchetti, G; Villani, C | 1 |
| Marconi, S; Stocchi, F | 1 |
| Cowen, PJ; Deakin, JF; Grahame-Smith, DG; Green, AR; Heal, DJ; Nimgaonkar, VL | 1 |
| Del Pesce, M; Di Bella, P; Forastieri, L; Paggi, A; Quattrini, A | 1 |
| Hanzal, F | 1 |
| Dinsmore, SR; Mrochek, JE; Ohrt, DW | 1 |
1 review(s) available for carbidopa and Hyperactivity, Motor
| Article | Year |
|---|---|
Factors associated with motor fluctuations and dyskinesia in Parkinson Disease: potential role of a new melevodopa plus carbidopa formulation (Sirio).
Topics: Antiparkinson Agents; Biological Availability; Carbidopa; Delayed-Action Preparations; Dopamine Agonists; Drug Combinations; Dyskinesia, Drug-Induced; Dyskinesias; Female; Humans; Hyperkinesis; Levodopa; Male; Parkinson Disease; Solubility; Time Factors | 2010 |
2 trial(s) available for carbidopa and Hyperactivity, Motor
| Article | Year |
|---|---|
[Efficacy and side-effects of long term L-dopa therapy in Parkinsonian syndromes (evaluated by CT scan as well) (author's transl)].
Topics: Adult; Benserazide; Brain; Carbidopa; Clinical Trials as Topic; Confusion; Electrocardiography; Electroencephalography; Female; Humans; Hydrazines; Hyperkinesis; Levodopa; Male; Middle Aged; Parkinson Disease, Secondary; Stomach Diseases; Tomography, X-Ray Computed | 1979 |
[Treatment of Parkinson's syndrome with L-dopa and L-carbidopa (author's transl)].
Topics: Adult; Aged; Carbidopa; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Combinations; Drug Interactions; Drug Therapy, Combination; Female; Humans; Hydrazines; Hyperkinesis; Levodopa; Male; Middle Aged; Parkinson Disease; Pyridoxine | 1976 |
4 other study(ies) available for carbidopa and Hyperactivity, Motor
| Article | Year |
|---|---|
Dyskinesia-Hyperpyrexia Syndrome in Parkinson's disease with Deep Brain Stimulation and high-dose levodopa/carbidopa and entacapone.
Topics: Antiparkinson Agents; Carbidopa; Catechols; Combined Modality Therapy; Deep Brain Stimulation; Drug Combinations; Drug Therapy, Combination; Fever; Humans; Hyperkinesis; Levodopa; Male; Middle Aged; Nitriles; Parkinson Disease | 2019 |
Tph2 gene deletion enhances amphetamine-induced hypermotility: effect of 5-HT restoration and role of striatal noradrenaline release.
Topics: 5-Hydroxytryptophan; Adrenergic Uptake Inhibitors; Amphetamine; Animals; Carbidopa; Corpus Striatum; Disease Models, Animal; Dopamine Agents; Female; Gene Expression Regulation; Hyperkinesis; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microdialysis; Motor Activity; Norepinephrine; Serotonin; Time Factors; Tryptophan Hydroxylase | 2015 |
Studies on the mechanisms by which clenbuterol, a beta-adrenoceptor agonist, enhances 5-HT-mediated behaviour and increases metabolism of 5-HT in the brain of the rat.
Topics: Animals; Behavior, Animal; Brain; Carbidopa; Clenbuterol; Ethanolamines; Fenclonine; Humans; Hydroxydopamines; Hyperkinesis; Kinetics; Male; Mice; Mice, Inbred C57BL; Oxidopamine; Quipazine; Serotonin; Stereotyped Behavior | 1983 |
Monitoring phenylalanine-tyrosine metabolism by high-resolution liquid chromatography of urine.
Topics: Aromatic Amino Acid Decarboxylase Inhibitors; Autistic Disorder; Carbidopa; Catechols; Child; Chromatography, Gas; Chromatography, Ion Exchange; Dihydroxyphenylalanine; Hippurates; Homovanillic Acid; Humans; Hyperkinesis; Intellectual Disability; Lactates; Mandelic Acids; Mass Spectrometry; Methods; Nervous System Diseases; Parkinson Disease; Phenylacetates; Phenylalanine; Spectrophotometry, Ultraviolet; Tyrosine | 1973 |